NIH
-
Complementary and alternative medicine use differs by race, economics
Use of complementary and alternative medicine differs by race and socioeconomic factors, study reports. Read MoreOctober 9, 2012
-
Host proteins can control HIV infection
The protein APOBEC3G contributes to spontaneous control of HIV-1 in vivo and may provide therapeutic benefits. Read MoreOctober 5, 2012
-
Proteins help flip tumor’s invasive switch
Vanderbilt investigators have identified how two key components of cancer's invasive "switch" — the series of signaling events that turn on a tumor cell’s invasive behavior — work together. Read MoreOctober 4, 2012
-
An orphan enzyme’s purpose
“Orphan” enzyme may play role in cancer growth, new research suggests. Read MoreOctober 4, 2012
-
Target acquired for aggressive tumor
New therapeutic target for angiosarcoma – an aggressive, highly fatal tumor of the blood vessels – identified. Read MoreSeptember 27, 2012
-
Cell entry ports for cold virus
The respiratory virus HMPV uses its fusion (F) protein – which interacts with cellular receptors called integrins – to bind to and enter target cells. Read MoreSeptember 25, 2012
-
HER2 may impact lung cancer therapy
A protein associated with aggressive breast cancers may also influence resistance of lung cancer to targeted therapies. Read MoreSeptember 21, 2012
-
How ‘Jedi’ disposes of dead neurons
The protein Syk is essential for clearing away neuron “corpses” in the developing peripheral nervous system. Read MoreSeptember 19, 2012
-
Caving for Cures project gains museum limelight
If you drop by the American Museum of Natural History the next time you visit New York, there is a good chance that you will see an exhibit highlighting Vanderbilt chemist Brian Bachmann’s "caving for drugs" research. Read MoreSeptember 17, 2012
-
Cells with LIP eat their neighbors
A transcription factor called LIP is capable of causing one cell to consume another. Read MoreSeptember 13, 2012